Eli Lilly News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

05.03.19	Lilly Gets FDA Priority Review Designation For Emgality Injection - Quick Facts (RTTNews)
04.03.19	Eli Lilly To Introduce Lower-priced Version Of Insulin Humalog - Quick Facts (RTTNews)
01.03.19	Lilly To Present Data For Taltz, Mirikizumab At AAD Annual Meeting (RTTNews)
19.02.19	Eli Lilly: Tanezumab 10 Mg Meets Primary Endpoint In Phase 3 Study - Quick Facts (RTTNews)
08.02.19	Elanco Animal Health To File Registration Statement On Lilly Divestiture (RTTNews)
08.02.19	Eli Lilly To Divest Remaining Stake In Elanco Animal Health Via Exchange Offer (RTTNews)
06.02.19	Eli Lilly Lowers FY19 Outlook - Quick Facts (RTTNews)
06.02.19	Eli Lilly And Co. Q4 adjusted earnings Miss Estimates (RTTNews)
04.02.19	Lilly : Baricitinib Meets Primary Endpoint In BREEZE-AD1 And BREEZE-AD2 (RTTNews)
01.02.19	Eli Lilly, Loxo Oncology Report Expiration Of HSR Act Waiting Period (RTTNews)
29.01.19	Pfizer, Lilly Announce Results From Phase 3 Study Of Tanezumab In OA Pain (RTTNews)
18.01.19	Lilly : Phase 3 Soft Tissue Sarcoma Study Fails Not Meet Primary Endpoints (RTTNews)
18.01.19	FDA Turns Down IMMU's Breast Cancer Drug, MGNX/LLY Deal Progresses, ZFGN Abuzz (RTTNews)
07.01.19	Lilly To Buy Loxo Oncology In $8.0 Bln Deal (RTTNews)
27.12.18	Innovent, Lilly Co-developed Tyvyt Gets China's NMPA Approval For CHL (RTTNews)
19.12.18	Eli Lilly Pulls Back Off Best Levels But Remains Firmly Positive (RTTNews)
19.12.18	Lilly Sees FY19 Results Above View; Hikes Dividend (RTTNews)
17.12.18	Eli Lilly: Taltz Meets Primary And Secondary Endpoints In Spirit-H2H Study (RTTNews)
13.12.18	Eli Lilly : FDA Grants Fast Track Designation To Baricitinib Development Program (RTTNews)
12.12.18	Lilly And AC Immune Enter Into License And Collaboration Agreement (RTTNews)
06.11.18	Eli Lilly Q3 Results Beat View; Lifts FY18 Outlook (RTTNews)
05.11.18	Eli Lilly: REWIND Trial Demonstrates MACE Reduction By Trulicity - Quick Facts (RTTNews)
31.10.18	Dr. Reddy's Launches Atomoxetine Capsules, Generic Version Of Strattera, In U.S. (RTTNews)
30.10.18	Elanco Names Todd S. Young as New Chief Financial Officer (Businesswire)
29.10.18	Dicerna Stock Surges On RNAi Deal With Lilly (RTTNews)
24.10.18	CMTA Fast Tracks NDA Filing, USNA In Good Health, DERM To Report Data In Apr. (RTTNews)
22.10.18	Lilly And Incyte Update Safety Analysis Of OLUMIANT (RTTNews)
04.10.18	Boehringer Ingelheim & Eli Lilly: Empagliflozin Meets Primary Efficacy Endpoint (RTTNews)
02.10.18	Eli Lilly: Phase 3 Studies Show URLi Meets Primary Efficacy Endpoint (RTTNews)
28.09.18	FDA Approves Lilly's Emgality For Preventive Treatment Of Migraine In Adults (RTTNews)
21.09.18	Lilly' Emgality Gets Positive CHMP Opinion For Prophylaxis Of Migraine In Adults (RTTNews)
20.09.18	Lilly's Elanco Animal Health Prices IPO Of 62.9 Mln Shares At $24.00/shr (RTTNews)
31.08.18	Biotech Stocks Facing FDA Decision In September (RTTNews)
02.08.18	Elanco Animal Health Files Registration Statement For IPO - Quick Facts (RTTNews)
24.07.18	Eli Lilly Revises Guidance; To Pursue IPO Of Elanco - Quick Facts (RTTNews)
24.07.18	Eli Lilly And Co. Q2 adjusted earnings Beat Estimates (RTTNews)
19.07.18	Lilly: Tradjenta's CARMELINA Cardiovascular Outcome Trial Meets Primary Endpoint (RTTNews)
18.07.18	Pfizer And Lilly Announce Positive Results From Phase 3 Trial Of Tanezumab (RTTNews)
28.06.18	ACRX Gets EC Nod, AQXP Tanks As LEADERSHIP 301 Fails, ZSAN Catches Eye (RTTNews)
25.06.18	Eli Lilly: Humulin R U-500 Administered In Insulin Pump Shows Improved A1C (RTTNews)
25.06.18	Boehringer Ingelheim & Eli Lilly: Empagliflozin Trials Meet Primary Endpoint (RTTNews)
25.06.18	Eli Lilly To Present Phase 3 Data For Galcanezumab, Lasmiditan - Quick Facts (RTTNews)
25.06.18	LLY Scores Win In Alimta Patent Suit, LXRX For The Long Haul, MNKD Breathes Easy (RTTNews)
23.06.18	Eli Lilly: Jardiance Reduces Risk Of Kidney Disease Progression In Diabetes (RTTNews)
23.06.18	Eli Lilly: Lispro Shows Improved Blood Sugar Control In Phase 1b Studies (RTTNews)
23.06.18	Eli Lilly: Trulicity Phase 2 Data Shows Efficacy In People With Type 2 Diabetes (RTTNews)
18.06.18	Lilly Declares Third-Quarter 2018 Dividend (PR Newswire)
13.06.18	CAH Closer To FDA Approval, Another Alzheimer's Disease Drug Fails, VTVT Tanks (RTTNews)
12.06.18	AstraZeneca, Eli Lilly To Discontinue Lanabecestat Trials In Alzheimer's (RTTNews)
12.06.18	Update on Phase 3 Clinical Trials of Lanabecestat for Alzheimer's Disease (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.14	1.54 %	K V
UBS Group	28.08	1.48 %	K V
Swiss Re	130.05	1.05 %	K V
Part Grp Hldg	1’266.00	0.96 %	K V
ABB	49.48	0.94 %	K V
Geberit	525.20	0.27 %	K V
Alcon	78.04	0.05 %	K V
Givaudan	3’868.00	-0.31 %	K V
CieFinRichemont	121.20	-0.57 %	K V
Sonova Hldg	301.00	-0.99 %	K V

mehr

18:08		TELL me! - der Schweizer Trading Podcast: Microsoft unter Kartellverdacht - Novartis auf einem guten Weg - bei Brenntag könnte das zyklische Tief 2025 kommen
17:58		Optimismus in Europa: Euro STOXX 50 zum Ende des Donnerstagshandels in der Gewinnzone
17:58		Freundlicher Handel in Frankfurt: LUS-DAX verbucht schlussendlich Gewinne
17:58		DAX aktuell: DAX zum Handelsende mit Zuschlägen
15:58		Börse Europa: STOXX 50-Börsianer greifen zu
12:26		Gewinne in Europa: STOXX 50 am Mittag mit Kursplus
09:28		Freundlicher Handel in Europa: Euro STOXX 50 zum Start fester
09:28		Börse Frankfurt in Grün: DAX beginnt Handel im Plus

18:08

TELL me! - der Schweizer Trading Podcast: Microsoft unter Kartellverdacht - Novartis auf einem guten Weg - bei Brenntag könnte das zyklische Tief 2025 kommen

17:58

Optimismus in Europa: Euro STOXX 50 zum Ende des Donnerstagshandels in der Gewinnzone

17:58

Freundlicher Handel in Frankfurt: LUS-DAX verbucht schlussendlich Gewinne

17:58

DAX aktuell: DAX zum Handelsende mit Zuschlägen

15:58

Börse Europa: STOXX 50-Börsianer greifen zu

12:26

Gewinne in Europa: STOXX 50 am Mittag mit Kursplus